The bacterial transposon Tn7 is distinguished by its ability to insert at a high frequency into a specific site in the Escherichia coli chromosome called attTn7. Tn7 insertion into attTn7 requires four Tn7-encoded transposition proteins: TnsA, TnsB, TnsC and TnsD. The selection of attTn7 is determined by TnsD, a sequence-specific DNA-binding protein. TnsD binds attTn7 and interacts with TnsABC, the core transposition machinery, which facilitates the insertion of Tn7 into attTn7. In this work, we report the identification of two host proteins, the ribosomal protein L29 and the acyl carrier protein (ACP), which together stimulate the binding of TnsD to attTn7. The combination of L29 and ACP also stimulates Tn7 transposition in vitro. Interestingly, mutations in L29 drastically decrease Tn7 transposition in vivo, and this effect of L29 on Tn7 transposition is specific for TnsABC⍣D reactions.
Introduction
Transposable elements are discrete DNA segments that can translocate between sites within a genome. Although transposable elements can usually insert into many different sites, most transposons do exhibit some degree of target-site selectivity (reviewed by Craig, 1997) . The bacterial transposon Tn7 is unusual in that it can utilize two distinct classes of target sites using two different transposition reactions. Using one class of target sites, Tn7 inserts at a high frequency into a specific site called attTn7 found in the chromosomes of many bacteria; alternatively, Tn7 also inserts at a low frequency into another class of non-attTn7 sites (Barth et al., 1976; Lichtenstein and Brenner, 1981; Craig, 1991; Wolkow et al., 1996) .
Multiple Tn7-encoded proteins, TnsA, TnsB, TnsC and TnsD (TnsABCϩD), mediate Tn7 transposition into attTn7 (Rogers et al., 1986; Waddell and Craig, 1988; Kubo and Craig, 1990; Bainton et al., 1993) . TnsD, a sequence-specific DNA-binding protein, is responsible for selecting the attTn7 target site (Waddell and Craig, 1988; Kubo and Craig, 1990; Bainton et al., 1993) and subsequently for recruiting the core transposition 5822 © Oxford University Press machinery to the target DNA. This machinery is a oligomeric complex containing both TnsA and TnsB, Sarnovsky et al., 1996) and TnsC, the transposition regulator (Stellwagen and Craig, 1997) . Thus, the role of TnsD in Tn7 transposition is to position the core transposition machinery at the Tn7 insertion site.
The binding of TnsD to attTn7 exerts considerable control over Tn7 transposition into attTn7. Previous studies have demonstrated that the initiation of the chemical steps, i.e. cleavage and joining steps, of the transposition reaction requires the recognition of attTn7 by TnsD. We have previously proposed that cleavage at the Tn7 ends occurs only after the formation of a nucleoprotein complex containing TnsABCϩD, attTn7 target DNA and Tn7 ends (Bainton et al., 1991 (Bainton et al., , 1993 . Although the selection of an appropriate target DNA takes place early in Tn7 transposition reaction, not all transposons do so at an early step. In contrast to Tn7, Tn10 selects its target sites at a late step in the transposition reaction; the Tn10 transposase does not interact with or capture the target DNA until the complete excision of the Tn10 element (Sakai et al., 1995; Kleckner et al., 1996; Sakai and Kleckner, 1997) . Regardless of the stage at which the target DNA enters the transposition reaction, the interaction of the transposase with appropriate DNA targets is a vital step in transposition.
Host-encoded proteins can also influence target-site selection. For example, the recruitment of the yeast retrovirus-like Ty3 element to its preferred insertion sites located within the promoters of genes transcribed by RNA polymerase (pol III), occurs through the direct interaction of the Ty3 integrase and the pol III transcription factors TFIIIB and TFIIIC (Kirchner et al., 1995) . Do host proteins also influence the target-site selectivity of Tn7? There has been no obvious requirement for host proteins in Tn7 transposition. Indeed, efficient reconstitution of Tn7 transposition in vitro has been accomplished using highly purified Tn7-encoded transposition proteins (Bainton et al., 1993) . However, it has been observed in previous work that the addition of crude extract to the transposition reaction can stimulate Tn7 transposition in vitro (Bainton et al., 1991) and more specifically that host proteins can stimulate TnsD binding to attTn7, suggesting that host proteins may be involved in Tn7 transposition (Bainton et al., 1993) .
To determine the identity and the roles of the host proteins that are involved in stimulating TnsD binding to attTn7 and potentially Tn7 transposition, we fractionated host-cell extracts using TnsD binding to attTn7 as an assay. Two host proteins, the ribosomal protein L29 and the acyl carrier protein (ACP), were identified that collaborate to assist the formation of TnsD-attTn7 complexes. L29 is a component of the 50S ribosomal subunit and can bind to 23S rRNA ; Wittmann- Noller and Nomura, 1996) ; ACP is an essential protein whose major role is in fatty acid biosynthesis as a carrier of fatty acids (reviewed by Magnuson et al., 1993) . In this report, we demonstrate that the combination of L29 and ACP can influence Tn7 transposition in vitro, suggesting that the interactions between L29, ACP and TnsD-attTn7 complexes may contribute to high-frequency insertion of Tn7 into attTn7. We have also found that L29 has a substantial impact on Tn7 transposition into attTn7 in vivo.
Results
Site-specific insertion of Tn7 into attTn7 requires the binding of TnsD to this target site. It has been observed previously that host proteins present in crude extracts can stimulate binding of TnsD to attTn7, as evaluated by a gel mobility-shift assay, resulting in the formation of a new slower-mobility TnsD-attTn7 complex (Figure 1 , lane 4 versus lane 3) (Bainton et al., 1993) . Host proteins do not bind to attTn7 in the absence of TnsD (Figure 1 , lane 2). It should be noted that in all DNA-binding reactions the amount of TnsD is limiting; the stimulation in TnsD-attTn7 complex formation is more apparent under these assay conditions. We have ruled out the involvement of HU, IHF, H-NS and FIS in the formation of TnsDattTn7 complexes; these small heat-stable proteins that have been shown to participate in various recombination reactions do not influence TnsD binding to attTn7 (data not shown). Thus, another host protein(s) must be involved in altering the formation of TnsD-attTn7 complexes.
Identification of two host factors that stimulate TnsD binding
To identify the host proteins that influence TnsD-attTn7 complex formation, we fractionated crude extracts (see
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Materials and methods) and evaluated fractions for their ability to promote TnsD-attTn7 complex formation at each purification step using the appearance of altered TnsD-attTn7 complexes as an assay. Fractionation of cell extracts over a phosphocellulose (PC) column separated the host activity into two components. One component bound to the PC column, PC bound , and contained a host protein(s) that could alter the migration of TnsD-attTn7 complexes. The TnsD-attTn7 complexes formed in the presence of the PC bound factor had migration patterns that were equivalent to TnsD-attTn7 complexes formed in the presence of unfractionated crude extract. In contrast, the other host component, PC flow through , enhanced TnsD binding to attTn7 in the presence of the PC bound factor, but could not influence TnsD-attTn7 complex formation alone.
The PC bound fraction was further fractionated by cation exchange (MonoS) and gel filtration (Superose 12), which resulted in Component 1. We found that Component 1 alone could alter the binding of TnsD to attTn7, resulting in the formation of a new slower-migrating TnsD-attTn7 complex ( Figure 2B , lane 3). We also found that the formation of Component 1 ϩ TnsD-attTn7 complexes could be greatly stimulated when the PC flow through component, which was identified as ACP (see below), was present in the attTn7 binding reactions ( Figure 2C , lanes 5-11). Analysis of the Superose 12 fractions by SDS-PAGE and Coomassie Blue staining revealed that a small polypeptide of~7.0 kDa ( Figure 2A ) coincided with fractions displaying Component 1 host activities. The identity of the 7.0 kDa protein was determined using amino-terminal sequencing; the first 12 amino acids of this protein were identified as MKAKELREKSVE. A protein homology search found this sequence to be identical to the ribosomal protein L29.
The PC flow through factor(s) were further fractionated by anion exchange (MonoQ) and two components, 2A and 2B, were identified that could influence the formation of L29 ϩ TnsD-attTn7 complexes. Components 2A and 2B were fractionated once more by gel filtration (Superose 12) and active host fractions were evaluated by SDS-PAGE and Coomassie Blue staining. Component 2A was identified as an~15.0 kDa protein which was found to coincide with fractions that could greatly enhance TnsD binding to attTn7 in the presence of L29 ( Figure 3A , lanes 3-8, and B, lanes 13-18). In contrast, Component 2B was identified as an~30.0 kDa protein which was found to coincide with fractions that caused the formation of several distinct slower-mobility L29 ϩ TnsD-attTn7 complexes ( Figures 4A, lanes 2-7, In summary, the fractionation of the host-cell extracts 11) were analyzed in each attTn7-binding reaction, using the gel mobility-shift assay. TnsD (6.7 ng) was present in lanes 2-11. ACP (15 ng) was present in lanes 4-11. Lane 3 contained 1.5 µg of wild-type crude extract. The reactions conditions are described in Materials and methods, and the results shown are of a scanned gel.
revealed that L29 causes the formation of slower-migrating TnsD-attTn7 complexes, and that (ACP) 1 and (ACP) 2 collaborate with L29 to stimulate binding of TnsD to attTn7 more than 20-fold compared with the binding of TnsD to attTn7 in the absence of host factors. Our purification procedure uses two different E.coli strains based on findings in our initial purification attempts. Note that we purified ACP from an L29 -strain which contained a deletion of 48 nucleotides within rpmC, the gene encoding L29, to prevent the contamination of ACP with wild-type L29. Since ACP is an essential protein, no ACP null mutants are available: therefore, L29 cannot be purified in the absence of wild-type ACP. Hence, we are unable to exclude the possibility that trace amounts of ACP exist in the L29 preparations.
Two forms of ACP can influence TnsD binding to attTn7 As described above, (ACP) 1 (Component 2A) and (ACP) 2 (Component 2B) can both alter the formation of L29 ϩ TnsD-attTn7 complexes. (ACP) 1 ϩ L29 enhances the binding of TnsD to attTn7 Ͼ20-fold, causing the formation of a slower-migrating TnsD-attTn7 complex ( Figure 5B , lane 6). In contrast, (ACP) 2 ϩ L29 causes the formation of several other distinct slower-migrating TnsD-attTn7 complexes; the formation of the higher-order complexes suggests the multiple ACP molecules may be capable of interacting with TnsD when bound to attTn7 ( Figure 5B , lane 7). (ACP) 2 ϩ L29 ϩ TnsD-attTn7 complexes can sometimes be detected in the presence of unfractionated extract (data not shown).
(ACP) 2 consists of two (ACP) 1 molecules linked covalently through disulfide bonds (Rock and Cronan, 1981 ; reviewed by Magnuson et al., 1993) . (ACP) 2 can be converted into (ACP) 1 in the presence of the reducing agent DTT. To demonstrate whether (ACP) 2 was indeed the form of ACP present in Component 2B, we evaluated the effects of (ACP) 2 on L29 ϩ TnsD-attTn7 complexes in the presence and absence of DTT, which promotes the conversion of (ACP) 2 into (ACP) 1 . We observed that when DTT was present in the binding reaction, (ACP) 2 resulted in the formation of (ACP) 2 ϩ L29 ϩ TnsD-attTn7 complexes that had migration patterns that were identical to TnsD-attTn7 complexes formed in the presence of (ACP) 1 ϩ L29 ( Figure 5B , lanes 6-8). We also found that the migration pattern of the (ACP) 2 polypeptide when treated with DTT is the same as that of (ACP) 1 , as evaluated by SDS-PAGE ( Figure 5A , lane 2). Thus, two distinct forms of ACP [(ACP) 1 and (ACP) 2 ] can influence the formation of L29 ϩ TnsD-attTn7 complexes; the ability of (ACP) 1 and (ACP) 2 to form L29 ϩ TnsD-attTn7 complexes that have different mobilities on non-denaturing polyacrylamide gels suggests that ACP is a constituent of the slower-migrating TnsD-attTn7 complexes.
L29 and ACP are present in the TnsD-attTn7-host complexes
We have presented evidence suggesting that both L29 and ACP are involved in stimulating TnsD binding to attTn7. Are L29 and ACP present in the TnsD-attTn7-host complexes? The fact that purified L29 causes a shift in mobility strongly suggests that it is a component in this complex; ACP, however, causes no additional shift. Therefore, to further examine this question, tritium ( 3 H)-labeled (ACP) 1 was used in the TnsD-binding reactions with unlabeled attTn7 DNA fragments. The mobility of the TnsD-attTn7 complexes formed in the presence of both 3 H-(ACP) 1 and L29 appeared to migrate identically to the TnsD-attTn7 complexes formed when [ 32 P]attTn7 was used to evaluate the effects of unlabeled (ACP) 1 on TnsD binding to attTn7 ( Figure 6 , lane 15 versus lanes 5 and 10). These data indicate that (ACP) 1 is a component of the slowermigrating TnsD-attTn7 complexes. The ability of the [ 3 H](ACP) 1 to interact with TnsD-attTn7 complexes only We also detected a novel complex on non-denaturing polyacrylamide gels in attTn7 binding reactions containing only L29 HH , a modified version of L29 containing a histidine purification tag and the HSV epitope tag at its C-terminus, and [ 3 H](ACP) 1 , suggesting that these two proteins can interact without TnsD (Figure 6, lane 14) . Although attTn7 DNA is present in the binding reaction, we found that neither L29 nor ACP is able to bind to attTn7 without TnsD (data not shown). Note that these slower-migrating complexes are not present in binding reactions containing 32 P-labeled attTn7 ( Figure 6 , lane 9). Thus, it is likely that L29 and ACP can interact through direct protein-protein interactions. In contrast, we have found that interactions between TnsD, L29 and ACP require the presence of the attTn7 target DNA, suggesting that stimulation in TnsD binding to attTn7 by L29 and ACP may also involve protein-DNA interactions (data not shown).
To demonstrate that L29 [63 amino acids (aa)] interacts with TnsD-attTn7 complexes, we evaluated the ability of L29 HH (63 ϩ 26 aa) to alter the formation of TnsDattTn7 complexes. We found that L29 HH ϩ TnsD-attTn7 complexes migrated more slowly than L29 ϩ TnsDattTn7 complexes ( Figure 7A , lane 6 versus lane 2). The formation of L29 HH ϩ TnsD-attTn7 complexes of altered mobility provides evidence that L29 is indeed a component of the TnsD-attTn7-host complexes formed in the presence of crude extracts. The formation of L29 HH ϩ TnsD-attTn7 complexes was also stimulated in the presence of (ACP) 1 ( Figure 7A, lane 7) . Note that along with the L29 HH ϩ TnsD-attTn7 complexes, another protein-DNA complex is present in the TnsD-binding reaction that migrates to a position identical to that of L29 ϩ TnsD-attTn7 complexes. This is likely to result from both L29 HH and wildtype L29 being present in the L29 HH protein preparation; on Coomassie-Blue-stained SDS-polyacrylamide gels both L29 HH and wild-type L29 are visible (data not shown). The presence of wild-type L29 in the L29 HH preparation suggests that L29 can form multimers, although we have no evidence indicating that the multimeric state of L29 is critical to its role in Tn7 transposition.
L29 was further determined to influence TnsD-attTn7 complex formation by: (i) showing that host extracts made from a strain containing an internal deletion of 16 amino acids within L29, L29 ∆9-24 , could no longer stimulate the formation of TnsD-attTn7 complexes ( Figure 7B , lane 6); (ii) establishing that the combination of purified L29 and the L29 ∆9-24 extract stimulates TnsD binding to attTn7 to a level that is indistinguishable from that of unfractionated wild-type host extracts ( Figure 7B , lane 7); and (iii) demonstrating that L29 (provided by K.Neirhaus) that was purified from a different purification procedure causes the formation of a protein-DNA complex whose migration pattern is identical to that of L29 ϩ TnsD-attTn7 complexes that is formed in the presence of our L29 preparation ( Figure 7B , lane 5). Together, these observations strongly suggest that L29 is a constituent of TnsD-attTn7 complexes formed in the presence of crude extract and is indeed involved in stimulating TnsD-attTn7 complex formation.
L29 and ACP can stimulate Tn7 transposition in vitro
We demonstrated above that L29 and ACP can affect TnsD binding to attTn7. Can L29 and ACP also influence Tn7 transposition? To determine whether L29 and/or ACP can alter Tn7 transposition in vitro, the effects of both host proteins on Tn7 insertion into an attTn7-containing target were evaluated in a reconstituted system using purified Tn7-encoded transposition proteins. The Tn7 transposition in vitro reaction is very efficient under standard reaction conditions, and thus does not permit the effects of L29 and ACP on Tn7 transposition to be adequately evaluated. However, we found that when the amount of TnsD in the transposition reaction is limiting, an effect of L29 and ACP on Tn7 transposition in vitro can be detected; other reaction conditions tested did not have notable effects on the transposition reaction (data not shown). It should be noted that the combination of L29 and ACP causes an increase of at least three-fold (for the 1/3X and 1/9X TnsD dilutions) in Tn7 insertion into the attTn7 target site (Figure 8, lanes 7-16) . The molar amounts of L29 and ACP present in transposition reactions are similar to TnsD levels; i.e. the amount of L29 and ACP needed to stimulate Tn7 transposition in vitro is not 
L29 plays a role in Tn7 transposition in vivo
We have also examined the effect of L29 on Tn7 transposition into the chromosomal attTn7 site in vivo. This was accomplished by evaluating the level of Tn7 insertions into attTn7 in the wild-type L29 and the L29 ∆9-24 strains by probing a Southern blot with a DNA probe specific for the attTn7 target site (data not shown). We found that a considerable fraction (1-3%) of the chromosomal attTn7 sites of the wild-type L29 strain received an Tn7 insertion; comparable levels of insertions have been observed for other strains . We were unable to detect Tn7 insertions into the chromosomal attTn7 site of the L29 ∆9-24 strain, indicating at least a 9-fold decrease in transposition. However, we found that when the L29 mutation was complemented by supplying the cells with Mating-out assays were performed using the following donor strains: PS166, PS167, PS168 and PS169. All of the donors strains contain an insertion of Tn7 in the attTn7 target site (attTn7::Tn7) and are resistant to trimethoprim (Tp R ). Strains PS168 and PS169 contain a wild-type allele of rpmC, the gene encoding L29, and strains PS166 and PS167 contain the rpmC106 allele, which results in a mutant form of L29 that is missing amino acids 9-24. Each donor strain also contained one of two target plasmids pOX38-attTn7 or pOX-Gen; both plasmid confer resistance to gentamycin (Gn R ). CW51 (Nal R , Rif R ) was the recipient strain in all mating reactions. Procedures used to evaluate the mating mixtures are described in the Materials and methods. We found that Tn7 insertion into the chromosomal attTn7 site in the L29 mutant strain (AM111-5) can be restored to wild-type levels by providing cells with L29 on a plasmid (data not shown). a The transposition frequency is equal to the number of transposition events and was determined by dividing the number of recipient cells obtaining a target plasmid which contained an Tn7 insertion (Nal R Rif R Tp R colonies) by the total number of recipient cells obtaining a target plasmid (Nal R Rif R Gen R colonies). b The rpmC106 allele was generated by a spontaneous deletion of 48 nucleotides near the 5Ј end of rpmC.
wild-type L29 on a plasmid, the level of transposition into the chromosomal attTn7 site was restored to that observed in the wild-type L29 strain. This finding indicates that the defect in Tn7 transposition is due to L29. We also evaluated the effects of L29 on Tn7 transposition using an assay that monitors Tn7 transposition from the chromosomal attTn7 site into a conjugable plasmid containing the essential attTn7 sequences (see Materials and methods). In cells containing wild-type L29, Tn7 transposition into attTn7 occurs at a high frequency (Table I) . Strikingly, in the L29 ∆9-24 strain, Tn7 insertion into attTn7 decreased Ͼ100-fold (Table I) . We also evalu-ated the effects of an L29 mutation on the non-TnsD Tn7 transposition pathway that directs Tn7 insertions to nonattTn7 target sites. Tn7 insertion into non-attTn7 target sites was similar in both the wild-type L29 and the L29 ∆9-24 strains. These results indicate that L29 plays an important role in Tn7 transposition into attTn7 within the cell. We have not yet been able to evaluate the effect of ACP on Tn7 transposition; since ACP is an essential protein, addressing this question is technically challenging.
These results support the view that L29 has an important role in directing Tn7 insertion in vivo into target DNAs, plasmid or chromosomal, that contain the TnsD binding site, i.e. attTn7, but not non-attTn7 target sites.
Discussion
The transposon-encoded protein TnsD is responsible for directing Tn7 insertions into the chromosomal site, attTn7: TnsD binds specifically to attTn7 and recruits the rest of the transposition machinery to this target site. In this work, we report the identification of two host-encoded proteins that together stimulate TnsD binding to attTn7. We also provide evidence that these host factors stimulate Tn7 transposition in vitro. Interestingly, a host factor(s) also influences Tn7 transposition in vivo.
L29 and ACP can stimulate TnsD binding to attTn7
We have identified two host proteins, L29 and ACP, that collaborate to stimulate the binding of TnsD to attTn7. L29 is a relatively small (63 aa) basic protein that binds to 23S ribosomal RNA and is also a component of 50S ribosomal subunits (Bitar, 1975; Urlaub et al., 1995; Wittmann-Liebold et al., 1995; Noller and Nomura, 1996) . The function of L29 in protein synthesis is not known; as L29 null mutants have not been characterized, it is not clear whether L29 is essential for cell viability. However, a strain containing an internal deletion of 16 amino acids, L29 ∆9-24 , is viable (Dabbs, 1979) . Ribosomal proteins have been implicated in cellular processes such as replication, transcription, RNA processing and DNA repair (reviewed by Wool, 1996) . Notably, this work is the first report of a ribosomal protein participating in bacterial transposition.
ACP is a small (77 aa) acidic protein that functions as a carrier of various fatty acids in several biosynthetic pathways, including fatty acid biosynthesis (reviewed by Magnuson et al., 1993) , phospholipid biosynthesis (reviewed by Cronan and Rock, 1996) , lipopolysaccharide biosynthesis (reviewed by Raetz, 1996) and activation of hemolysin (Issartel et al., 1991) . The ACP polypeptide is post-translationally modified through the transfer of 4Ј-phosphopantetheine (4Ј-PP) from coenzyme A to Ser36 of ACP, forming (ACP) 1 . (ACP) 1 is further modified at the terminal sulfhydryl moiety by the enzymatic attachment of various fatty acids, which leads to the formation of several different acylated derivatives of (ACP) 1 . (ACP) 1 can also form covalent dimers with itself through the formation of disulfide bonds, forming (ACP) 2 (Rock and Cronan, 1981; Magnuson et al., 1993) .
We report here that ACP ϩ L29 results in the formation of TnsD-attTn7 complexes that are similar in their mobilities (on non-denaturing polyacrylamide gels) to the TnsDattTn7-host complexes that are formed in the presence of crude extracts. Since we found that L29 ϩ unmodified 5828 ACP (the ACP polypeptide which lacks the 4ЈPP moiety and was a gift from C.Walsh) can also stimulate TnsD binding to attTn7, it seems unlikely that the prosthetic groups of modified forms of ACP play a role in the formation of L29 ϩ TnsD-attTn7 complexes (data not shown). Thus, it is most likely that a region common to all ACP molecules is responsible for interacting with L29 ϩ TnsD-attTn7 complexes. It should be noted that we have not directly evaluated acylated derivatives of ACP for their effects on TnsD binding to attTn7; therefore, we cannot speculate on the potential role of acyl-ACPs on Tn7 transposition.
The evidence presented here suggests that both L29 and ACP can associate with TnsD when it is bound to attTn7. We found that an altered form of L29 causes the formation of TnsD-attTn7 complexes that migrate more slowly than L29 ϩ TnsD-attTn7 complexes, providing evidence that L29 is indeed a component of the TnsDattTn7-host complexes. We have also shown that ACP is a constituent of the TnsD-attTn7-host complexes by demonstrating that slower-mobility TnsD-attTn7 complexes can be visualized in the presence of [ 3 H](ACP) 1 ϩ L29.
L29 and ACP can stimulate Tn7 transposition
Many features of Tn7 transposition into attTn7 in vivo have been realized using an in vitro transposition system, a highly efficient reaction requiring only purified TnsABCϩD, the mini-Tn7 element and attTn7-containing target DNAs. Prior to this work, there was no obvious role for host proteins in Tn7 transposition in vitro, although a stimulation of Tn7 transposition in vitro has been detected in the presence of host extracts. We have demonstrated here that L29 and ACP can enhance Tn7 transposition into attTn7 in vitro at least three-fold. It should be noted, however, that both L29 and ACP are necessary to detect any increase in the amount of simple insertion products produced; thus, the host activities of L29 and ACP in Tn7 transposition in vitro are dependent upon each other. It is important to note that the in vitro transposition assay was developed and optimized without host proteins. Thus, it may be that our standard assay conditions are not conducive for studying the effects of host proteins on Tn7 transposition in vitro; it is possible that more dramatic effects can be observed under other assay conditions. ACP has also been reported to stimulate nicking at the 3Ј ends of Tn3 by the purified Tn3 transposase, although it is not clear whether ACP alters the binding of the Tn3 transposase to the 3Ј ends (Maekawa et al., 1996) . Here we have been able to show a direct effect of ACP on Tn7 transposition in vitro. Owing to the essential role of ACP in vivo, its effects on Tn7 transposition in vivo have not yet been evaluated.
Most interestingly, L29 was found to play a vital role in Tn7 transposition in vivo. Tn7 transposition into attTn7 decreases Ͼ100-fold when intact L29 is absent from cells. Moreover, L29 specifically affects Tn7 transposition reactions involving TnsD; this specificity seems reasonable, since L29 was identified based on its role in enhancing TnsD binding to attTn7.
L29 and ACP may play a regulatory role in Tn7 transposition
Tn7 transposition is a tightly regulated process. The selection of appropriate target sites controls the initial steps of the transposition reaction. TnsD is responsible for selecting the attTn7 target site by binding to a specific sequence within attTn7 (Waddell and Craig, 1988; Bainton et al., 1993) . It has been previously established by DNA footprinting analysis that TnsD interacts with TnsC, thus recruiting the TnsAϩB transposase bound to the Tn7 ends to attTn7. Thus, a nucleoprotein complex, containing TnsABCϩD, attTn7 and the mini-Tn7 ends, is essential for promotion of Tn7 transposition into attTn7.
In this work, we have demonstrated that the combination of L29 and ACP enhances the formation of TnsD-attTn7 complexes and stimulates Tn7 transposition in vitro. Moreover, we have observed that L29 is extremely important for high-frequency Tn7 insertion into attTn7 in vivo. Hence, host proteins may indeed play an essential role in Tn7 transposition within the cell.
By what mechanism might L29 and ACP influence Tn7 transposition? The fundamental activity of L29 and ACP is to increase the apparent affinity of TnsD for attTn7. Perhaps L29 and ACP promote conformational changes within TnsD that allow TnsD to bind more stably to attTn7, thereby increasing the frequency of Tn7 transposition into attTn7. It is possible that L29 and ACP directly function as an anchor, securing TnsD to attTn7 through protein-protein and/or protein-DNA interactions. We have presented some evidence here showing potential proteinprotein interactions between L29 and ACP; whether L29 and/or ACP can bind to attTn7 when bound to TnsD remains to be established.
Why might L29 and ACP be involved in Tn7 transposition in vivo? One attractive hypothesis is that L29 and ACP modulate Tn7 transposition into attTn7 by signaling to Tn7 when cellular conditions are favorable or unfavorable for insertion. An intriguing but unexamined issue is the possibility that the amount of L29 available to participate in Tn7 transposition may vary during the different cellular growth phases. The transient availability of L29 may serve to modulate Tn7 insertion into attTn7, thereby linking Tn7 transposition to cellular growth. As a component of the 50S ribosomal subunit, L29 exists in two different forms (free and bound) within cells. We have provided strong evidence in this work that free L29 ϩ ACP has a significant impact on both binding of TnsD to attTn7 and Tn7 transposition in vitro. Since the majority of L29 is found in the ribosomes during logarithmic growth, it is intriguing to speculate that 50S ribosomal subunits, which contain L29, might also be capable of influencing TnsD binding to attTn7. It has been shown in the case of the ribosomal protein S10 (nusE) that both free S10 and S10, present in 30S ribosomal subunits, and 70S ribosomes can participate in transcription antitermination by phage λ N protein (Das et al., 1985) .
It is more difficult to speculate about how information about cell growth can be transmitted in a ACP-dependent fashion. ACP is a very abundant protein and is available during all cellular growth phases. We have evidence that the unmodified ACP polypeptide (apo-ACP) can influence TnsD binding to attTn7; therefore, it seems unlikely that the different forms of ACP can regulate transposition. Since only the combination of ACP and L29 can stimulate TnsD-attTn7 complex formation and Tn7 transposition in vitro, it seems reasonable to suggest that ACP might also assist L29 in modulating Tn7 transposition within the cell. Understanding how L29 and ACP influence Tn7 transposition may provide insight into how the molecular mechanisms of Tn7 transposition are linked to cellular metabolism and may also help reveal the critical features of TnsD interactions with attTn7.
Materials and methods
Bacterial strains L29 was identified from crude extract prepared from HN1125 [E.coli galK2 hupA16::Kan R hupB11::Tet R supO str R ] (Wada et al., 1988) . HN1511 [E.coli galK2 supO str R ] is the isogenic parent of HN1525 (Bachmann, 1972) . ACP and (ACP) 2 were identified from crude extract prepared from AM111-5 [E.coli gdhA2 his-95 metB1 relA1 rpmC rna-19 spoT1] (Dabbs, 1979) . A19 [E.coli gdhA2 his-95 metB1 relA1 rna-19 spoT1] is the isogenic parent of AM111-5.
Host crude extracts made from the following strains were used to evaluate their effect on TnsD binding to attTn7. P1vir transduction was used to transfer each mutation into the same strain background (Miller, 1972) . The HU -strain was made by P1 transduction of hupA16::Kan R hupB11::Tet R from HN1525 into HN1511. The FIS -strain was created by P1 transduction of fis767::Kan R from OH76 into HN1511. The IHFstrain was made by P1 transduction of hip::Cm R from BD784 and himA::Tet R from BD783 (laboratory strains) into HN1511. The H-NSstrain was made by transducing HN1511 with a hns205::Tet R P1vir lysate (Dersch et al., 1993) .
The following strains were used in the mating-out assay. PS164 was made by P1 transduction of attTn7::Tn7 from OH14 (Hughes, PhD. thesis) into a AM111-5 strain background. PS165 was made by P1 transduction of Tn7 from OH14 into an A19 strain background. Several strains, PS166, PS167, PS168 and PS169, served as donors in the mating-out assay. PS166 consists of PS164 containing pOX38-Gen (a derivative of the conjugable F factor which has gentamycin resistance, Gen R ), and PS167 consists of PS164 containing pOX38-attTn7 (pOXGen containing attTn7 sequences). PS168 is PS165 containing pOX38-Gen and PS169 PS165 containing pOX38-attTn7. CW51 [E.coli F -ara arg lac proXIII recA56 nal R rif R ] was the recipient strain used in all matings (Waddell and Craig, 1988) .
TnsD . His was purified from NCM533 [E.coli K-12[λ ϩ ] lacZ::Tn5la-cI q1 ] (Bainton et al., 1993) . L29 HH was purified from BL21(λDE3) (Novagen). Tritium-labeled ACP was prepared from SJ16 [E.coli F -panD zad220::Tn10 metB relA1 λ r λ -gyrA216] (Jackowski and Rock, 1981) .
PCR primers
The following DNA primers were used during the cloning of TnsD . His and L29 HH (see below). NLC129, 5Ј-TTATCTGTTAAGCATAAA-GACTGGC-3; NLC186, 5Ј-CGAGGATCCGCCAAAACAGCCAAG-CTTGGCTACAGG-3Ј; NLC287, 5Ј-GGGAATTCCATATGAAAGCA-AAAAGAGCTGCGTGAGAAGAGCG-3Ј; NLC288, 5Ј-CCGCTCG-AGACCCGCCTTCTCGTTCAGTAAAGTCTTAACGCG-3Ј.
Affinity purification of TnsD . His TnsD . His contains all 508 amino acids of TnsD (with the exception of a change in the second amino acid of Gly to Ser) fused to a 15-aminoacid linker containing a 10-residue C-terminal histidine tag; its activities are indistinguishable from those of authentic TnsD (data not shown). The TnsD expression plasmid, pPLS24, was constructed by inserting the NcoI-SpeI fragment from pKAO41 (Orle and Craig, 1991) and the SpeI-BamHI PCR fragment amplified from pKAO41, which was obtained using PCR primers NLC129 and NLC186, into the NcoI-BamHI site of pGD108 (Ghrayeb et al., 1984) .
The TnsD . His protein was purified from NCM533 (Shand et al., 1991) containing the pPLS24 tnsD histidine tagged plasmid. Cells were grown at 17°C to an OD 600 ϭ 1.0 in LB medium supplemented with 100 µg/ml carbenicillin, IPTG was added to 100 µM and the cells were allowed to grow for an additional 4 h. The cells were harvested by centrifugation and resuspended at 4°C in Buffer A (60 mM imidazole, 20 mM Tris pH 7.9, 500 mM NaCl) at 0.5 g cells/ml. The cells were then lysed by sonication and centrifuged at 26 000 g for 30 min, and the resulting supernatant was filtered through a 0.45 µm syringe filter (Nalgene). The filtrate was applied to Ni 2ϩ Sepharose B resin (Pharmacia) in batch and the resin was washed several times in Buffer A containing 10% glycerol. The washed Ni 2ϩ resin was then packed into a 10 ml column, which was washed with several column volumes of Buffer A containing 10% glycerol, and Buffer B (100 mM imidazole, 20 mM Tris pH 7.9, 500 mM NaCl, 10% glycerol). TnsD . His was eluted from the column with Buffer C (200 mM imidazole, 20 mM Tris pH 7.9, 500 mM NaCl, 10% glycerol). Peak fractions were pooled, dialyzed against 500 mM KCl, 50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 2 mM DTT and 25% glycerol, and stored at -80°C. Approximately 25 µg/g of cells were collected; the final TnsD . His preparation was Ͼ95% pure.
Purification of L29 and ACP
We identified the ribosomal protein L29 and the ACP by fractionating a crude cell extract from HN1525 and AM111-5, respectively. Cells were grown at 37°C to an OD 600 ϭ 1.0 in LB medium. All purification steps were performed at 4°C, unless otherwise specified. For each gram of cell pellet, four milliliters of lysis buffer (10 mM potassium phosphate pH 7.0, 1 mM EDTA, 5 mM β-mercaptoethanol (β-ME), 0.1 mM PMSF, 500 mM NaCl) was used to resuspend the cell pellets. The cells were sonicated and the cellular debris was removed by centrifugation at 26 000 g for 30 min at 4°C. Polyethyleneimine (PEI) pH 7.9 was added to a final concentration of 0.5% over 10 min, and the mixture was centrifuged for 15 min at 26 000 g. The host extract was boiled while stirring for two min and the denatured proteins were removed by centrifugation at 12 000 g for 15 min. The remaining proteins were precipitated with ammonium sulfate, which was added to 100% saturation. Lysis buffer was used to resuspend the ammonium sulfate pellet, which was dialyzed overnight in a low-salt buffer (10 mM potassium phosphate pH 7.0, 1 mM EDTA, 5 mM β-ME, 0.1 mM PMSF).
The lysate was then loaded onto a 2.5 ml phosphocellulose column (Whatman P11) and bound proteins were eluted over a 50 ml linear gradient, 75-769 mM potassium phosphate (pH 7.0). Fractions containing host factors that caused the formation of slower-mobility TnsD-attTn7 complex (active fractions) eluted in~300 mM potassium phosphate. The active fractions were pooled, dialyzed into 50 mM potassium phosphate, 50 mM NaCl, and 1 mM EDTA, and loaded onto a MonoS HR 5/5 column (Pharmacia). Proteins that bound to the MonoS column were eluted over a 20 ml linear gradient of 50-525 mM NaCl and the host activity was recovered at around 320 mM NaCl. The active fractions were pooled and concentrated using the Centricon-3 centrifugal concentrators (3000 mol. wt cut-off) (Amicon) and further fractionated using a Superose 12 HR 10/20 (Pharmacia) column (25 ml). The proteins were collected (250 ml fractions) from the gel filtration column into a highsalt buffer (20 mM Tris pH 7.0, 1 mM EDTA, 525 mM NaCl). Fractions 58-68 were found to be active and were collectively referred to as Component 1. The identity of the protein that co-purified with the active fraction was determined by N-terminal sequencing.
When purifying (ACP) 1 and (ACP) 2 , the flow-through fractions from the phosphocellulose column were pooled, dialyzed into 20 mM Tris buffer (pH 7.0), 50 mM NaCl and 1 mM EDTA, and loaded onto a l ml MonoQ HR 5/5 column (Pharmacia). The proteins were eluted with a 20 ml 50-525 mM linear gradient. The activity of the fractions from the MonoQ column were evaluated in the presence of Component 1 (L29). Fractions containing (ACP) 1 (Component 2) eluted at~420 mM NaCl, whereas fractions containing (ACP) 2 (Component 3) eluted at 475 mM NaCl. Both sets of fractions were combined into separate pools and concentrated via Centricon-3 centrifugal concentrators (Amicon), and loaded onto a Superose 12 HR 10/30 column; 250 µl fractions were collected into a high-salt buffer (20 mM Tris pH 7.0, 1 mM EDTA, 525 mM NaCl), and active fractions were pooled. Amino-terminal sequencing was used to identify the protein that co-purified with the activity.
Affinity purification of L29 HH L29 . HSV . His (L29 HH ) contains all 63 amino acids of L29 fused to a 26-amino-acid linker containing a 12-residue herpes simplex virus (HSV) epitope and a six-residue His tag. The gene encoding L29, rpmC, was amplified from the chromosome of NLC28 using PCR methodology. For cloning purposes, PCR primers NLC287 and NLC288 were designed, which allow XbaI and XhoI restriction sites to flank the rpmC gene. The L29 expression plasmid, pPLS42, was constructed by inserting the XbaIXhoI rpmC PCR fragment into the XbaI-XhoI site of pET-25b (Novagen). The L29 HH protein was purified from the E.coli strain BL21(λ DE3), which contains a plasmid with the gene encoding L29 (rpmC) fused to the HSV and His tags. Cells were grown at 37°C to an OD 600 between 0.7 and 0.8 in LB medium supplemented with 100 mg/ml of carbenicillin, IPTG was added to 100 µM and growth was allowed to continue for an additional 2.5 h. The cells were harvested by centrifugation and resuspended at 4°C in 60 mM imidazole, 20 mM Tris pH 7.9, 500 mM NaCl. The cells were then lysed by sonication and centrifuged at 26 000 g for 30 min, and the resulting cleared lysate was filtered through a 0.45 µm 5830 syringe filter. The filtrate was then loaded onto a Ni 2ϩ Sepharose B column (Novagen) and the column was washed with the same buffer and with 100 mM imidazole, 20 mM Tris pH 7.9, 500 mM NaCl. The L29 HH fraction was eluted with 200 mM imidazole, 20 mM Tris (pH 7.9), 500 mM NaCl, dialyzed overnight into 10 mM sodium phosphate, 1 mM EDTA, 0.1 mM PMSF, 5 mM β-ME, and loaded onto a Mono Q HR 5/5 column. L29 HH eluted at~300 mM NaCl. Wild-type L29, expressed from the chromosomal rpmC gene, co-eluted with the L29 HH .
Preparation of tritium-labeled ACP 3 H-labeled ACP was prepared essentially as described by Rock and Cronan (1981) , using E.coli strain SJ16 (PanD -), a gift from John Cronan.
Gel mobility-shift assay
The effect of host proteins on binding of TnsD to attTn7 was evaluated using a gel-mobility shift assay as described by Bainton et al. (1993) . All of the reaction mixtures (20 µl final volume) contained buffer components [50 mM Tris-HCl pH 8.0, 140 mM KCl, 1 mM EDTA, 1.8 mM dithiothreitol (DTT), 9.8% (v/v) glycerol, 340 µg/ml bovine serum albumin (BSA), 17 µg/ml sheared salmon-sperm DNA, 0.01 pmol of 32 P-labeled attTn7 DNA fragments] plus 6.7 ng TnsD and various amounts of each host fraction or purified protein. In experiments evaluating 3 H-labeled ACP,~0.5 pmol of unlabeled attTn7 DNA fragments were used. All reactions were incubated for 20 min at room temperature and electrophoresed through 8.75% polyacrylamide gels (29:1 acrylamide:N,NЈ-methylene-bisacrylamide) in Tris-borate-EDTA (TBE) buffer at 11.5 V/cm for 3-4 h. The gels were dried under a vacuum and exposed to X-ray film or PhosphorImager screen. Gels containing 3 H-ACP 1 were treated with the autoradiography enhancer Enlightning (Dupont) prior to drying and exposure to X-ray film.
In vitro transposition assay
The in vitro transposition reactions were performed essentially as described by Bainton et al. (1993) . Reaction mixtures (100 µl volume) contained 0.25 nM pMIM donor plasmid, 2.5 nM pRM2 attTn7 target plasmid, 25 mM HEPES, 2.0 mM DTT, 2.5 mM Tris pH 8.0, 2.0 mM ATP, 50 mg/ml BSA, 100 µg/ml tRNA 20 nM TnsA-His, 3 nM TnsBHis, 10 nM TnsC, various concentrations of TnsD . His,~14 nM L29, 11 nM ACP and 15 mM magnesium acetate (MgAc). The reaction mixtures (96 µl), which included everything except the MgAc, were assembled on ice and allowed to incubate at 30°C for 30 min. MgAc (4.0 µl) was added to 15 mM and the reaction mixtures were incubated for an additional 30 min. Reactions were stopped by phenol/chloroform (1:1 v/v) extraction, the DNA was ethanol precipitated, digested with ScaI, and analyzed by agarose gel electrophoresis and Southern hybridization using a DNA probe specific for the mini-Tn7 element. The blots were examined by autoradiography and PhosphorImager screens (Molecular Dynamics).
Mating-out assay
The effect of L29 on Tn7 transposition was evaluated using the matingout assay (Waddell and Craig, 1988) . To evaluate the influence of L29 on low-frequency Tn7 insertion into non-attTn7 sites, we used as a target a derivative of the conjugable F plasmid, pOX38-Gen. To evaluate the effect of L29 on high-frequency Tn7 insertion into attTn7, we used as a target a derivative of pOX38-Gen containing the attTn7 DNA sequences, which will be referred to as pOX38-attTn7. Insertions into pOX38-Gen and pOX38-attTn7 were evaluated in both the L29 wildtype (L29 wt ) and the L29 mutant (L29 ∆9-24 ) strains. The donor strains contained a chromosomal copy of Tn7, which confers resistance to trimethoprim (Tp R ) and either pOX38-Gen or pOX38-attTn7, which are resistant to gentamycin (Gen R ). The recipient strain, CW51, was resistant to nalidixic acid (Nal R ) and rifampicin (Rif R ). The total number of recipient cells obtaining an F plasmid was determined by selecting for Nal R Rif R Gen R colonies. Recipients obtaining F plasmids with Tn7 insertions were detected by selecting for Nal R Rif R Tp R colonies. The transposition frequency was calculated by dividing the number of recipient cells that received an F plasmids containing an Tn7 insertion by the total number of recipient cells that received an F plasmid.
